Global association dedicated to improving the understanding & clinical management of inherited GI cancers for affected families. #HereditaryGICancer#CGAIGC26
🎗️ November is also #GastricCancerAwarenessMonth, and we’re delighted to share this short video from Ophir Gilad, MD.
🧬He shares findings from his #CGAIGC26 presentation in Denver earlier this month, “Penetrance of CDH1 Pathogenic Variants: A Multicenter Analysis and Meta-Analysis from the GASTRIC Consortium.”
Drawing on data from more than 7,500 individuals in 228 families across 12 North American centers, the team estimated that people with a pathogenic CDH1 variant had a 26% risk of gastric cancer by age 80 for men & 28% for women.
🎥In the video, Ophir Gilad MD, explains why gastric cancer risk estimates have varied across studies & how these findings can help care teams discuss risk w/ patients & families.
🎧 Missed Ophir Gilad’s conversation w/ Emma Keel, MS, CGC (@pAla2Arg ) about the GASTRIC Consortium?
🎙️ Listen to the podcast 👉🔗 https://t.co/67L0ie60P3
📖 Read the companion blog post 👉🔗 https://t.co/L1sYW1jZzZ
🤝 Is your center interested in joining the GASTRIC Consortium? Find out how to get involved here 👉 🔗https://t.co/BMMJNYPSRe
#HereditaryGICancer #StomachCancer #GastriCancer
💜 Today is #WorldPancreaticCancerDay!
🚨Is your pancreatic cancer surveillance program on our global map? 🌍
➡️ People at high risk of pancreatic cancer & their care teams need to know where to find an expert surveillance center. Since 2021, CGA-IGC has maintained the Global Pancreatic Cancer Surveillance Resource, now available through our Find a Clinic map. To our knowledge, it’s the only global directory of pancreatic cancer surveillance programs.
➡️ This #PancreaticCancerAwarenessMonth, you can help more people find expert care.
📍 Check the map and bookmark it for the next time a patient or family needs a referral 👉🔗 https://t.co/zNJXXz7Mb6
➕ Is your program missing? Submit your center’s details and invite colleagues at other surveillance programs to add theirs 👉🔗 https://t.co/Ls4E9FxOY7
🔁 Share the map with referring teams & families at high risk.
If you repost, tag CGA-IGC and use #WorldPancreaticCancerDay so others can find the resource too.
#PancreaticCancerAwarenessMonth #HereditaryGICancer
🎥 Couldn’t join us in Denver for #CGAIGC26, or miss our “How We Do It” session on advanced practice providers (APPs)?
📍Watch Jennifer Fijor (@GutGalz) share a brief recap of “Defining, Expanding, Adapting Advanced Practice Provider (APP) Roles in Hereditary Cancer Care: Models, Challenges, and Real-World Practice.”
🎧 Hear more from Heather Hannon DNP APRN-NP OCN ACGN, Carrie Thompson DNP, APRN, ANP-BC, CPNP-PC, OCN, ACGN, and Margaret Hornung, DNP FNP-BC, ACGN in our two-part APP podcast series.
In the latest episode, they share how APPs support patients beyond genetic testing, from coordinating surveillance to building trust through ongoing care.
🎙️Listen to Part 2 👉 🔗 https://t.co/ew3Dk2Qdi9
🎙️Catch up: on Part 1 👉 🔗 https://t.co/Bop6HstJU7
📖 Prefer to read? Megan Dwyer, MS, CGC, Co-Vice Chair of our Communications Committee, shares highlights from both episodes in her CGA-IGC blog post. Read it here 👉 🔗 https://t.co/SAIdda5jmJ
#HereditaryGICancer
@MSpringerGC
🏆 Maureen Mork from @UTMDAnderson was not only the very deserving recipient of the 2026 Dennis J. Ahnen Outstanding Service Award at #CGAIGC26, but also delivered an insightful presentation on an important topic, "Novel Approaches to Genetic Testing."
Ms Mork shared insights into the ongoing challenge of low cascade genetic testing uptake among at-risk relatives and explored potential strategies to improve participation.
🔹 Innovative approaches include patient navigation, reducing financial barriers, and at-home genetic testing.
🔹 No single intervention has consistently achieved the desired results, highlighting the need for creative, multimodal approaches to improve testing uptake.
🎥 Watch this short interview 👇to hear Ms Mork's key takeaways and what they mean for the multidisciplinary #hereditarygicancer care team.
#CascadeTesting #GeneticCounseling
That's a wrap on #CGAIGC26! 🎉
Our 30th Annual Meeting in Denver was officially our most highly attended meeting to date, bringing together 530+ participants from 15 countries! 🌎
A huge THANK YOU to our attendees, speakers, presenters, committees, council members, sponsors, and exhibitors for making this milestone edition such a success!
🏖️ See you next year in Long Beach, California, for #CGAICC27!
Dr. @josepereag, EOCRC Global Research Collaborative Advisor discussed Genetic Drivers Of Immunometabolism Influence Risk And Survival In Early- Onset Colorectal Cancer. Thanks to Dr. Perea for supporting patients globally and all his work with Fight CRC over the years!! #CGAIGC26 @CGAIGC
🎥 Does AI-assisted colonoscopy improve lesion detection in patients with #LynchSsyndrome?
At #CGAIGC26, @RHuneburg from University Hospital Bonn, Germany, shares findings from the CADLY-2 trial, published in The Lancet Gastroenterology & Hepatology
Watch this short video 👇 to hear the key findings and their implications for Lynch syndrome surveillance.
#hereditarygicancer
📣We're excited to kick off #PancreaticCancerAwarenessMonth & sharing exciting advances in pancreatic cancer treatment!
At #CGAIGC26, Dr. Lindsay Davis, a medical oncologist from the @CUCancerCenter highlights emerging treatment options, including PARP inhibitors, immunotherapy, & promising new KRAS-targeted therapies.
With KRAS mutations found in approximately 93% of pancreatic cancers, these developments offer new hope for more personalized treatment approaches & improved patient outcomes.
📽️Watch this short sound bite 👇 to hear Dr. Davis share the latest developments & what they could mean for patients!
ASCO member and JCO PO co-author Dr. Bryson Katona of @PennMedicine explains the data from “Pancreatic Imaging Findings in BRCA1/BRCA2/ATM/PALB2 Carriers”.
Learn more: https://t.co/ycrruMEzDP
‼️ #CGAIGC26 simultaneous publication by Katona, et al.
Longitudinal Pancreatic Imaging Findings in BRCA1, BRCA2, ATM, and PALB2 Heterozygotes Undergoing Pancreatic Cancer Surveillance: A Prospective PRECEDE Consortium Study
Read the full publication. https://t.co/DOdVG7izUo
🔛 NOW: Presidential Plenary II Session at #CGAIGC26, where Samantha Kasselman presents her abstract “Pancreatic Imaging Findings of PRECEDE Consortium Participants with Pathogenic Germline Variants in Breast Cancer Susceptibility Genes (ATM, BRCA1, BRCA2, PALB2),” which was simultaneously published in the Journal of Precision Oncology (@JCOPO_ASCO).
🎥 Missed the Randall Burt Lecture at #CGAIGC26 or couldn't join us in Denver?
🙏to our Communications Committee member Benjamin Lerner, MD who caught up with James Ford, MD following his Randall Burt Lecture, “A Pre-Cancer Atlas for Hereditary Colorectal Cancer: Using FAP as a Model System.”
🧬 In this insightful interview, Dr. Ford shares insights into how familial adenomatous polyposis (FAP) can serve as a model for understanding the earliest stages of colorectal cancer development and the potential implications for future cancer prevention strategies.
🎧 Take a few minutes to listen to this fascinating conversation and hear directly from Dr. Ford!
#HereditaryGICancer #CancerResearch
@MSpringerGC@EdEsplin@asaf_maoz@HHampel1@AparajitaSingh0
#CGAIGC26 provided the perfect opportunity to celebrate an important achievement in person: Lynch syndrome finally has its own dedicated ICD-10 code!
To mark this milestone, we hosted a special "HOW WE DO IT" session: PETITIONING FOR AND OBTAINING AN ICD-10 CODE FOR LYNCH SYNDROME, featuring Andrea Dwyer, MPH, and Peter Stanich, MD, 2 key collaborators in this effort, who shared the journey, challenges, & collaborative work that made this achievement possible.
Many🙏 to @FightCRC for garnering broad support from numerous organizations & individuals to make all of this possible!
🎥 Thanks to our past Communications Committee Chair @MSpringerGC for catching up with Andrea (Andi) Dwyer and Peter Stanich following the session to capture a quick sound bite!
#HereditaryGICancer
Melyssa Aronson takes the stage in the first Presidential Plenary session at #CGAIGC26 to present her abstract "Assessment of the 2022 Diagnostic Criteria for Constitutional Mismatch Repair Deficiency Syndrome (CMMRD) and Diagnoses of Individuals Referred to the International Replication Repair Consortium (IRRDC)," which is simultaneously published in the Journal of Precision Oncology (@JCOPO_ASCO). 👏
‼️ #CGAIGC26 simultaneous publication by Aronson, et al.
Assessment of the 2022 Constitutional Mismatch Repair Deficiency Syndrome (CMMRD) Diagnostic Criteria Using the International Replication Repair Deficiency Consortium (IRRDC)
Read the full publication. https://t.co/lgmF9hPCPc